[Treatment of prostatic, corpus uteri and kidney neoplasms (hypernephromas) in general practice].
D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003534:Cyproterone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004715:Endometriosis / Q000188:drug therapy; D004967:Estrogens / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D014594:Uterine Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004967:Estrogens; D011372:Progestins; D003534:Cyproterone; D011241:Prednisone
Die internistische Behandlung des Prostata-, Corpus-uteri- und Nierenkarzinoms (Hypernephrom.